Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9–14 years: results of the long-term extension of the DoRIS randomised trial

Authors: Deborah Watson-Jones, John Changalucha, Caroline Maxwell, Hilary Whitworth, Paul Mutani, Troy J Kemp, Beatrice Kamala, Jackton Indangasi, George Constantine, Ramadhan Hashim, David Mwanzalima, Rebecca Wiggins, Devis Mmbando, Nicholas Connor, Miquel A Pavon, Brett Lowe, Saidi Kapiga, Philippe Mayaud, Silvia de Sanjosé, Joakim Dillner, Richard J Hayes, Charles J Lacey, Ligia Pinto, Kathy Baisley

Published: 2025-01-29

DOI: 10.1016/s2214-109x(24)00477-7

Source: Full article


Abstract

No abstract found.